LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 921

Search options

  1. Article ; Online: The (human) respiratory rate at rest.

    Schramm, Wolfgang

    Journal of mathematical biology

    2022  Volume 85, Issue 5, Page(s) 60

    Abstract: All schoolchildren know how often they breathe, but even experts don't know exactly why. The aim of this publication is to develop a model of the resting spontaneous breathing rate using physiological, physical and mathematical methods with the aid of ... ...

    Abstract All schoolchildren know how often they breathe, but even experts don't know exactly why. The aim of this publication is to develop a model of the resting spontaneous breathing rate using physiological, physical and mathematical methods with the aid of the principle that evolution pushes physiology in a direction that is as economical as possible. The respiratory rate then follows from an equation with the parameters [Formula: see text]-production rate of the organism, resistance, static compliance and dead space of the lungs, the inspiration duration: expiration duration - ratio and the end-expiratory [Formula: see text] fraction. The derivation requires exclusively secondary school mathematics. Using the example of an adult human or a newborn child, data from the literature then result in normal values for their breathing rate at rest. The reason for the higher respiratory rate of a newborn human compared to an adult is the relatively high [Formula: see text]-production rate together with the comparatively low compliance of the lungs. A side result is the fact that the common alveolar pressure throughout the lungs and the common time constant is a consequence of the economical principle as well. Since the above parameters are not human-specific, there is no reason to assume that the above equation could not also be applicable to many animals breathing through lungs within a thorax, especially mammals. Not only physiology and biology, but also medicine, could benefit: Applicability is being discussed in pulmonary function diagnostics, including pathophysiology. However, the present publication only claims to be a theoretical concept of the spontaneous quiet breathing rate. In the absence of comparable animal data, this publication is intended to encourage further scientific tests.
    MeSH term(s) Humans ; Adult ; Animals ; Infant, Newborn ; Child ; Respiratory Rate ; Lung ; Mammals
    Language English
    Publishing date 2022-10-25
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 187101-8
    ISSN 1432-1416 ; 0303-6812
    ISSN (online) 1432-1416
    ISSN 0303-6812
    DOI 10.1007/s00285-022-01790-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Book ; Online: Akkadische Logogramme

    Schramm, Wolfgang

    2010  

    Keywords Writing systems, alphabets ; History: earliest times to present day ; Ancient history: to c 500 CE ; Ancient History (Ancient history: to c 500 CE) ; Writing systems ; Arcadian Logograms ; Akkadisches Handwörterbuch ; Sternbild
    Size 1 Online-Ressource
    Publisher Universitätsverlag Göttingen
    Document type Book ; Online
    Note German ; Open Access
    HBZ-ID HT021030280
    Database ZB MED Catalogue: Medicine, Health, Nutrition, Environment, Agriculture

    More links

    Kategorien

  3. Book ; Online: Ein Compendium sumerisch-akkadischer Beschwörungen

    Schramm, Wolfgang

    2008  

    Keywords History: earliest times to present day ; Other non-Christian religions ; KCB 651 ; KBA 651 ; Ancient Orientalism ; Akkadische Sprache ; Enki ; Eridu ; Gin ; Kur ; Marduk
    Size 1 Online-Ressource
    Publisher Universitätsverlag Göttingen
    Document type Book ; Online
    Note German ; Open Access
    HBZ-ID HT021028892
    Database ZB MED Catalogue: Medicine, Health, Nutrition, Environment, Agriculture

    More links

    Kategorien

  4. Article ; Conference proceedings: Haemostasis and transfusion

    Schramm, W.

    perioperative management in elderly patients ; [expert meeting] ; Graz, Austria, October 27 - 28, 2000 ; proceedings

    2001  

    Author's details guest eds.: W. Schramm
    Language English
    Publishing country Switzerland
    Document type Article ; Conference proceedings
    Note In: Infusion therapy and transfusion medicine. - ISSN 1424-5485. - 28 (2001),2, S. 95 - 118
    HBZ-ID HT013054081
    Database Catalogue ZB MED Medicine, Health

    Kategorien

  5. Article: Explorative cost-effectiveness analysis of colorectal cancer recurrence detection with next-generation sequencing liquid biopsy in Spain, France, and Germany.

    Schramm, Wendelin / Hollenbenders, Yasmin / Kurscheidt, Maximilian

    Therapeutic advances in gastroenterology

    2024  Volume 17, Page(s) 17562848241248246

    Abstract: Background: Next-generation sequencing liquid biopsy (NGS-LB) for colorectal cancer (CRC) detection and surveillance remains an expensive technology as economies of scale have not yet been realized. Nevertheless, the cost of sequencing has decreased ... ...

    Abstract Background: Next-generation sequencing liquid biopsy (NGS-LB) for colorectal cancer (CRC) detection and surveillance remains an expensive technology as economies of scale have not yet been realized. Nevertheless, the cost of sequencing has decreased while sensitivity has increased, raising the question of whether cost-effectiveness (CE) has already been achieved from the perspective of European healthcare systems.
    Objectives: This health economic (HE) modeling study explores the CE of NGS-LB for CRC based on direct treatment costs compared to standard care without liquid biopsy in Spain, France, and Germany.
    Methods: A structured literature search was used to collect evidence from 2009 to 2020 on the stage-dependent quality of life (quality-adjusted life-years, QALY), efficacy, and total direct treatment costs (TDC) of NGS-LB. A decision-analytic Markov model was developed. Over the remaining lifetime, cumulative life expectancy (LE), TDC, and QALYs were calculated for 60-year-old men and women in CRC stage III with different assumed effects of NGS-LB of 1% or 3% on improved survival and reduced stage progression, respectively.
    Results: The use of NGS-LB increases LE by 0.19 years in Spanish men (France: 0.19 years, Germany: 0.13 years) and by 0.21 years in Spanish women (France: 0.21 years, Germany: 0.14 years), respectively. The 3% discounted cost per QALY gained was 35,571.95 € for Spanish men (France: 31,705.15 €, Germany: 37,537.68 €) and 35,435.71 € for Spanish women (France: 31,295.57 €, Germany: 38,137.08 €) in the scenario with 3% improved survival and reduced disease progression. Compared to the other two countries, Germany has by far the highest TDC, which can amount to >80k euros in the last treatment year.
    Conclusion: In this explorative HE modeling study, NGS-LB achieves generally accepted CE levels in CRC treatment from the health system perspective in three major European economies under assumptions of small improvements in cancer recurrence and survival. Confirmation of these findings through clinical trials is encouraged.
    Language English
    Publishing date 2024-05-10
    Publishing country England
    Document type Journal Article
    ZDB-ID 2440710-0
    ISSN 1756-2848 ; 1756-283X
    ISSN (online) 1756-2848
    ISSN 1756-283X
    DOI 10.1177/17562848241248246
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Digital Diabetes Self-Management: A Trilateral Serial.

    Schramm, Wendelin

    Journal of diabetes science and technology

    2018  Volume 12, Issue 3, Page(s) 709–711

    Abstract: The way diabetes patients cope with their disease in day-to-day routines is decisive for the development or the prevention of medical complications. Smartphones have created the ubiquitous environment to support health care with mobile applications ( ... ...

    Abstract The way diabetes patients cope with their disease in day-to-day routines is decisive for the development or the prevention of medical complications. Smartphones have created the ubiquitous environment to support health care with mobile applications (mHealth). This article comments on the publication by Offringa et al in JDST, which is one of few studies that tries to isolate the effects of a diabetes app. At the same time, it is a good example to discuss general aspects of mHealth in diabetes care. Treatment context, eHealth literacy, interoperability, and efficiency will determine the success of diabetes apps. The development has not yet reached its end. A triple quality feedback loop linking persons with diabetes, health care providers, and mHealth providers is suggested.
    MeSH term(s) Delivery of Health Care ; Diabetes Mellitus ; Humans ; Mobile Applications ; Smartphone ; Telemedicine
    Language English
    Publishing date 2018-03-07
    Publishing country United States
    Document type Journal Article
    ISSN 1932-2968
    ISSN (online) 1932-2968
    DOI 10.1177/1932296818761973
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: New directions to develop therapies for people with hemophilia.

    Gogia, Pooja / Tarantino, Michael / Schramm, Wolfgang / Aledort, Louis

    Expert review of hematology

    2023  Volume 16, Issue 6, Page(s) 417–433

    Abstract: Introduction: The past few decades have seen a tremendous advancement in the management of hemophilia. Whether it is improved methods to attenuate critical viruses, recombinant bioengineering with decreased immunogenicity, extended half-life replacement ...

    Abstract Introduction: The past few decades have seen a tremendous advancement in the management of hemophilia. Whether it is improved methods to attenuate critical viruses, recombinant bioengineering with decreased immunogenicity, extended half-life replacement therapies to mitigate the burden of repeated infusion treatments, novel nonreplacement products to avoid the drawback of inhibitor development with its attractive subcutaneous administration and then the introduction of gene therapy, the management has trodden a long way.
    Areas covered: This expert review describes the progress in the treatment of hemophilia over the years. We discuss, in detail, the past and current therapies, their benefits, drawbacks, along with relevant studies leading to approval, efficacy and safety profile, ongoing trials, and future prospects.
    Expert opinion: The technological advances in the treatment of hemophilia with convenient modes of administration and innovative modalities offer a chance for a normal existence of the patients living with this disease. However, it is imperative for clinicians to be aware of the potential adverse effects and the need for further studies to establish causality or chance association of these events with novel agents. Thus, it is crucial for clinicians to engage patients and their families in informed decision-making and tailor individual concerns and necessities.
    MeSH term(s) Humans ; Hemophilia A/therapy ; Factor VIII/adverse effects ; Half-Life ; Hemophilia B/therapy ; Factor IX/adverse effects
    Chemical Substances Factor VIII (9001-27-8) ; Factor IX (9001-28-9)
    Language English
    Publishing date 2023-03-08
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2516804-6
    ISSN 1747-4094 ; 1747-4086
    ISSN (online) 1747-4094
    ISSN 1747-4086
    DOI 10.1080/17474086.2023.2184341
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: "Thromboinflammation in COVID-19: can α2-macroglobulin help to control the fire?": Comment from Seitz et al.

    Seitz, Rainer / Gürtler, Lutz / Schramm, Wolfgang

    Journal of thrombosis and haemostasis : JTH

    2023  Volume 21, Issue 3, Page(s) 704–705

    MeSH term(s) Humans ; Pregnancy ; Female ; Pregnancy-Associated alpha 2-Macroglobulins ; Thromboinflammation ; COVID-19 ; Inflammation ; Thrombosis ; Enzyme Inhibitors ; Transcription Factors
    Chemical Substances Pregnancy-Associated alpha 2-Macroglobulins ; Enzyme Inhibitors ; Transcription Factors
    Language English
    Publishing date 2023-03-01
    Publishing country England
    Document type Letter ; Comment
    ZDB-ID 2112661-6
    ISSN 1538-7836 ; 1538-7933
    ISSN (online) 1538-7836
    ISSN 1538-7933
    DOI 10.1016/j.jtha.2023.01.005
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Book ; Thesis: Proteinurie Screening und Intervention bei Diabetes Mellitus

    Schramm, Wendelin

    das PROSIT-Projekt in München

    2000  

    Author's details vorgelegt von Wendelin Schramm
    Language German
    Size 89 S., Ill., graph. Darst., 21 cm
    Publishing country Germany
    Document type Book ; Thesis
    Thesis / German Habilitation thesis München, Univ., Diss., 2000
    HBZ-ID HT012970735
    Database Catalogue ZB MED Medicine, Health

    Kategorien

  10. Book ; Online ; Conference proceedings: 34th Hemophilia Symposium

    Scharrer, I. / Schramm, W.

    Hamburg 2003

    2005  

    Author's details edited by I. Scharrer, W. Schramm
    Keywords Anesthesiology ; Blood transfusion ; Epidemiology ; Hematology ; Orthopedic surgery ; Pediatrics
    Language English
    Publisher Springer-Verlag Berlin Heidelberg
    Publishing place Berlin, Heidelberg
    Document type Book ; Online ; Conference proceedings
    HBZ-ID TT050387539
    ISBN 978-3-540-22886-8 ; 978-3-540-27022-5 ; 3-540-22886-1 ; 3-540-27022-1
    DOI 10.1007/b138513
    Database ZB MED Catalogue: Medicine, Health, Nutrition, Environment, Agriculture

    Kategorien

To top